NO970350L - Forbindelser anvendelige som anti-formeringsmidler og GARFT-inhibitorer - Google Patents
Forbindelser anvendelige som anti-formeringsmidler og GARFT-inhibitorerInfo
- Publication number
- NO970350L NO970350L NO970350A NO970350A NO970350L NO 970350 L NO970350 L NO 970350L NO 970350 A NO970350 A NO 970350A NO 970350 A NO970350 A NO 970350A NO 970350 L NO970350 L NO 970350L
- Authority
- NO
- Norway
- Prior art keywords
- compounds
- garft
- inhibitors
- compounds useful
- useful
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 7
- 239000003795 chemical substances by application Substances 0.000 title abstract 3
- 239000003944 phosphoribosylglycinamide formyltransferase inhibitor Substances 0.000 title abstract 2
- 101000606741 Homo sapiens Phosphoribosylglycinamide formyltransferase Proteins 0.000 abstract 2
- 102100039654 Phosphoribosylglycinamide formyltransferase Human genes 0.000 abstract 2
- 230000001028 anti-proliverative effect Effects 0.000 abstract 2
- 239000003112 inhibitor Substances 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D517/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having selenium, tellurium, or halogen atoms as ring hetero atoms
- C07D517/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having selenium, tellurium, or halogen atoms as ring hetero atoms in which the condensed system contains two hetero rings
- C07D517/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Transplantation (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NO970350A NO308997B1 (no) | 1994-07-28 | 1997-01-27 | Forbindelser anvendelige som anti-formeringsmidler og GARFT- inhibitorer, samt mellomprodukter og farmasøytisk blanding derav |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US1994/008522 WO1996003407A1 (en) | 1994-07-28 | 1994-07-28 | Compounds useful as antiproliferative agents and garft inhibitors |
| SG1996008313A SG44827A1 (en) | 1994-07-28 | 1994-07-28 | Compounds useful as antiproliferative agents and garft inhibitors |
| NO970350A NO308997B1 (no) | 1994-07-28 | 1997-01-27 | Forbindelser anvendelige som anti-formeringsmidler og GARFT- inhibitorer, samt mellomprodukter og farmasøytisk blanding derav |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO970350D0 NO970350D0 (no) | 1997-01-27 |
| NO970350L true NO970350L (no) | 1997-03-12 |
| NO308997B1 NO308997B1 (no) | 2000-11-27 |
Family
ID=26665124
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO970350A NO308997B1 (no) | 1994-07-28 | 1997-01-27 | Forbindelser anvendelige som anti-formeringsmidler og GARFT- inhibitorer, samt mellomprodukter og farmasøytisk blanding derav |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0783507B1 (no) |
| JP (1) | JP3473956B2 (no) |
| AT (1) | ATE242253T1 (no) |
| AU (1) | AU698868B2 (no) |
| DE (1) | DE69432801T2 (no) |
| DK (1) | DK0783507T3 (no) |
| ES (1) | ES2201079T3 (no) |
| FI (1) | FI112661B (no) |
| NO (1) | NO308997B1 (no) |
| NZ (1) | NZ271766A (no) |
| RU (1) | RU2136686C1 (no) |
| SG (1) | SG44827A1 (no) |
| WO (1) | WO1996003407A1 (no) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5831100A (en) * | 1995-06-07 | 1998-11-03 | Agouron Pharmaceuticals, Inc. | Syntheses of optically pure compounds useful as GARFT inhibitors and their intermediates |
| NL1014751C2 (nl) * | 2000-03-24 | 2001-09-25 | Marijke Cristiaans | Middel ter bevordering van borstgroei. |
| US20040043959A1 (en) * | 2002-03-04 | 2004-03-04 | Bloom Laura A. | Combination therapies for treating methylthioadenosine phosphorylase deficient cells |
| WO2004113328A1 (en) * | 2003-06-25 | 2004-12-29 | Pfizer Inc. | Convergent asymmetric synthesis route to produce a key intermediate towards the synthesis of a garft inhibitor |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4123550A (en) | 1977-10-31 | 1978-10-31 | Syntex (U.S.A.) Inc. | Bicyclo[3.1.0]hexylethylaminocarbonyl-substituted heteroaryl cardiovascular agents |
| ZA861235B (en) * | 1985-03-08 | 1986-10-29 | Univ Princeton | Pyrido(2,3-d)pyrimidine derivatives |
| EP0438261A3 (en) * | 1990-01-16 | 1992-02-26 | Takeda Chemical Industries, Ltd. | Condensed heterocyclic glutamic acid derivatives, their production and use |
| PT674516E (pt) * | 1992-12-16 | 2000-05-31 | Agouron Pharma | Compostos de 5-tiapirimidinona e 5-selenopirimidinona substituidos antiproliferativos |
-
1994
- 1994-07-28 RU RU97103519/04A patent/RU2136686C1/ru not_active IP Right Cessation
- 1994-07-28 WO PCT/US1994/008522 patent/WO1996003407A1/en not_active Ceased
- 1994-07-28 EP EP94925701A patent/EP0783507B1/en not_active Expired - Lifetime
- 1994-07-28 DK DK94925701T patent/DK0783507T3/da active
- 1994-07-28 ES ES94925701T patent/ES2201079T3/es not_active Expired - Lifetime
- 1994-07-28 AT AT94925701T patent/ATE242253T1/de not_active IP Right Cessation
- 1994-07-28 JP JP50570496A patent/JP3473956B2/ja not_active Expired - Fee Related
- 1994-07-28 NZ NZ271766A patent/NZ271766A/xx unknown
- 1994-07-28 AU AU75520/94A patent/AU698868B2/en not_active Ceased
- 1994-07-28 DE DE69432801T patent/DE69432801T2/de not_active Expired - Fee Related
- 1994-07-28 SG SG1996008313A patent/SG44827A1/en unknown
-
1997
- 1997-01-24 FI FI970318A patent/FI112661B/fi not_active IP Right Cessation
- 1997-01-27 NO NO970350A patent/NO308997B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JP3473956B2 (ja) | 2003-12-08 |
| FI112661B (fi) | 2003-12-31 |
| WO1996003407A1 (en) | 1996-02-08 |
| DE69432801T2 (de) | 2003-12-04 |
| ATE242253T1 (de) | 2003-06-15 |
| RU2136686C1 (ru) | 1999-09-10 |
| FI970318A0 (fi) | 1997-01-24 |
| NZ271766A (en) | 1999-01-28 |
| FI970318L (fi) | 1997-03-05 |
| ES2201079T3 (es) | 2004-03-16 |
| AU7552094A (en) | 1996-02-22 |
| DK0783507T3 (da) | 2003-09-15 |
| NO970350D0 (no) | 1997-01-27 |
| NO308997B1 (no) | 2000-11-27 |
| JPH10504541A (ja) | 1998-05-06 |
| EP0783507A1 (en) | 1997-07-16 |
| AU698868B2 (en) | 1998-11-12 |
| EP0783507B1 (en) | 2003-06-04 |
| DE69432801D1 (de) | 2003-07-10 |
| SG44827A1 (en) | 1997-12-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO308248B1 (no) | Forbindelser som er anvendbare som antiproliferative midler og GARFT-inhibitorer, samt farmasøytisk preparat | |
| NO944643D0 (no) | Protein-kinase-C-hemmere | |
| NO971889L (no) | Forbindelser og sammensetninger for levering av aktive midler | |
| EE200100485A (et) | Uudsed ühendid ja kompositsioonid proteaasi inhibiitoritena | |
| NO944430L (no) | 4-mercaptoacetylamino-[2Åbenzazepinon(3)-derivater, og anvendelse som enkefalinaseinhibitorer | |
| MY119820A (en) | Guanidine mimics as factor xa inhibitors | |
| DK0889877T3 (da) | Meta-substituerede phenylenderivater og deres anvendelse som alfav-beta3-integrin-antagonister eller -inhibitorer | |
| NZ240230A (en) | Mercaptoacetylamide derivatives; preparation, use and pharmaceutical compositions thereof | |
| LU91758I2 (fr) | Denosumab et ses dérivés pharmaceutiquement acceptables (PROLIA®) | |
| UA27100A1 (uk) | Заміщеhі піроли, що мають активhість іhгібіторів протеіhкіhази с, а також їх фармацевтичhо прийhятhі кислотhо-адитивhі солі і фармацевтичhа композиція | |
| NO992492L (no) | Benzamidoaldehyder og deres anvendelse som cystein-protease-inhibitorer | |
| ATE189390T1 (de) | Antiproliferative substituierte 5-thiapyrimidinon-und 5-selenopyrimidinonverbindungen | |
| DK0625987T3 (da) | Aminoacetylmercaptoacetylamid-derivater, der kan anvendes som inhibitorer af enkephalinase og ACE | |
| DK1097173T3 (da) | Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler | |
| NO954768D0 (no) | N-alkyltiopolyaminderivater som radiobeskyttende midler | |
| DK0471756T3 (da) | Saccharinderivater, der er egnede som proteolytiske enzyminhibitorer, og fremstilling deraf | |
| DK0579681T3 (da) | Krystallinsk tiagabin-hydrochlorid-monohydrat, dets fremstilling og dets anvendelse | |
| IT1276162B1 (it) | Geranilgeranil-derivati,procedimento per la loro preparazione e relative composizioni farmaceutiche | |
| ES2088128T3 (es) | Aminosulfonilureas inhibidoras de acat. | |
| MD502G2 (ro) | Derivaţi noi ai adenozinei, procedee de preparare a lor, compoziţii farmaceutice ce le conţin | |
| DK0996435T3 (da) | Aminosyrederivater anvendelige til behandling af slagtilfælde | |
| NO970350D0 (no) | Forbindelser anvendelige som anti-formeringsmidler og GARFT-inhibitorer | |
| HUP0002727A2 (hu) | Eljárás fibrinogén csökkentésére benzotiofénszármazékok felhasználásával |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |